PharmaAudit Services
Site, TMF and Database Audit
Inspection Preparation
CRO Evaluation
SOP Development
GCP Testing & Training
GCP Training
GCP Knowledge Testing
Free GCP Games
Case Studies
Mock Inspection
TMF Audit
Administration
Home Page
Contact Us
GCP Tests

Answer the questions below and then click the button. The next page will mark your answers and show you how well you have done compared with the previous people who have taken the tests.

Test: General Considerations for Clinical Trials - ICH E8

Question Number 1:

According to ICH E8 what Type of Study would the following be?

  • Dose-tolerance studies
  • Single and multiple dose PK and/or PD studies
  • Drug interaction studies
A
 Human Pharmacology
B
 Therapeutic Exploratory
C
 Therapeutic Confirmatory
D
 Therapeutic Use

Question Number 2:

According to ICH E8 what type of study would have the following as an objective?

"provide an adequate basis for assessing the benefit/risk relationship to support licensing"
A
 Human Pharmacology
B
 Therapeutic Exploratory
C
 Therapeutic Confirmatory
D
 Therapeutic Use

Question Number 3:

What is the following statement from ICH E8 defining?

The XXXXX of the study should be clearly stated and may include exploratory or confirmatory characterisation of safety and/or efficacy and/or assessment of pharmacokinetic parameters and pharmacological, physiological, biochemical effects.
A
 Endpoints
B
 Objectives
C
 Design
D
 Rationale

Question Number 4:

ICH E8 makes a statement about compliance. What completes the statement below?

"Methods used to evaluate patient usage of the test drug should be ......"
A
 documented where applicable
B
 consistent across the development program
C
 predefined in the protocol
D
 specified in the protocol and the actual usage documented

Question Number 5:

ICH E8 states:

"The study protocol should have a XXXXXXXX that is appropriate for the objectives and design of the study, taking into account the method of subject allocation, the measurement methods of response variables, specific hypotheses to be tested, and analytical approaches to common problems including early study withdrawal and protocol violations."

What is missing from the statement?
A
 detailed statistical section
B
 specified analysis plan
C
 statistical analysis plan
D
 section

 
(c) PharmaAudit 2009
All rights reserved
PharmaAudit
Home Page
Contact Us
Related Companies
PharmaSchool Training
PharmaXM Online Testing
Services
Routine Audits
Inspection Preparation